---
title: "TESTOSTERONE CYPIONATE 200MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, T... — FDA record D-0179-2022 | Is It on Recall"
description: "Lack of assurance of sterility"
url: https://isitonrecall.com/recall/fda-drug-d-0179-2022-testosterone-cypionate-200mg-ml-inj-1-in-ethyl-oleate-injectable-rx-only-talon-compounding-pharmacy/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# TESTOSTERONE CYPIONATE 200MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand... — FDA record D-0179-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Oct 12, 2021. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: TESTOSTERONE CYPIONATE 200MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- **Reason**: Lack of assurance of sterility
- **Classification**: Class II
- **Recalling firm**: Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- **Quantity**: 1229 vials
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0179-2022

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0179-2022%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot: T1007302021:72 BUD: 01/26/2022; T1005182021:09 BUD: 11/15/2021; T1008112021:73 BUD: 02/07/2022; T1004092021:40 BUD: 10/09/2021; T1006182021:37 BUD: 12/15/2021; T1005242021:71 BUD: 11/20/2021; T1006072021:06 BUD: 12/04/2021; T0606222021:35 BUD: 12/19/2021; T0605112021:23 BUD:11/07/2021 ; T0608162021:19 BUD: 02/12/2022; T1009132021:25 BUD: 03/12/2022; T1004272021:41 BUD: 10/24/2021; T0604152021:26 BUD: 10/12/2021; T1006302021:53 BUD: 12/27/2021; T1008022021:01 BUD: 01/29/2022; T1008302021:73 BUD: 02/26/2022; T1008052021:84 BUD: 02/01/2022; T1007152021:72 BUD: 01/11/2022; T1005112021:54 BUD: 11/07/2021; T1008042021:66 BUD: 01/31/2022; T1007062021:95 BUD: 01/02/2022; T1008302021:73 BUD: 02/26/2022; T1008052021:84 BUD: 02/01/2022; T1007152021:72 BUD: 01/11/2022; T1005112021:54 BUD: 11/07/2021; T1006142021:21 BUD: 12/11/2021; T1008042021:66 BUD: 01/31/2022; T1005102021:94 BUD: 11/06/2021; T1007282021:89 BUD: 01/24/2022; T1009222021:75 BUD: 03/21/2022; T1005052021:79 BUD: 11/01/2021; T1008192021:65 BUD: 02/15/2022; T1007132021:14 BUD: 01/09/2022; T1008162021:35 BUD: 02/12/2022; T0607282021:28 BUD: 01/24/2022; T1006022021:06 BUD: 11/29/2021; T1006222021:31 BUD: 12/19/2021; T1004292021:70 BUD: 10/26/2021; T1007212021:82 BUD: 01/17/2022; T1006282021:88 BUD: 12/25/2021; T1004222021:18 BUD: 10/19/2021; T1009082021:11 BUD: 03/07/2022; T1007082021:50 BUD: 01/04/2022; T1009212021:76 BUD: 03/20/2022; T1008312021:01 BUD: 02/27/2022; T0507062021:21 BUD: 01/02/2022; T1004152021:11 BUD: 10/12/2021; T1004192021:50 BUD: 10/16/2021; T1005132021:31 BUD: 11/09/2021; T1008252021:57 BUD: 02/21/2022; T1009152021:06 BUD: 03/14/2022; T1007232021:57 BUD: 01/19/2022; T1006162021:17 BUD: 12/13/2021; T1007122021:16 BUD: 01/08/2022; T1006102021:50 BUD: 12/07/2021; T1005282021:72 BUD: 11/24/2021; T0209082021:89 BUD: 03/08/2022; T0106092021:28 BUD: 11/07/2021; T0205112021:63 BUD: 11/07/2021; T0604152021:26 BUD: 10/12/2021; T0106092021:53 BUD: 11/07/2021; T0205112021:63 BUD: 11/07/2021; T0209092021:89 BUD: 03/08/2022; T0109032021:43 BUD: 11/07/2021 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

United States including Washington, D.C. and Puerto Rico

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Washington](https://isitonrecall.com/state/washington/)

## Dates in the source

- **Report date**: Nov 17, 2021
- **Recall initiation date**: Oct 12, 2021
- **Center classification date**: Nov 8, 2021
- **Termination date**: Oct 4, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0179-2022%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Vita Pharmacy, LLC dba Talon Compounding Pharmacy records](https://isitonrecall.com/brand/vita-pharmacy-llc-dba-talon-compounding-pharmacy/)